Related Experiment Videos
Lymphoproliferative and myeloproliferative disorders
1Department of Equine Internal Medicine, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, USA.
The Veterinary Clinics of North America. Equine Practice
|January 19, 1999
Summary
Equine hematopoietic and lymphoid neoplasia nomenclature is clarified, detailing lymphoproliferative and myeloproliferative disorders. Diagnostic methods like histochemistry and bone marrow analysis aid in identifying these equine cancers.
Area of Science:
- Veterinary Pathology
- Equine Medicine
- Hematology
Background:
- Nomenclature for equine hematopoietic and lymphoid neoplasia is complex and often confusing.
- Accurate terminology is crucial for understanding and diagnosing these conditions in horses.
Purpose of the Study:
- To clarify the nomenclature of hematopoietic and lymphoid neoplasia in horses.
- To discuss recognized lymphoproliferative and myeloproliferative disorders in equine species.
- To outline essential diagnostic techniques for suspected cases.
Main Methods:
- Review and clarification of existing terminology.
- Discussion of specific equine lymphoproliferative disorders.
- Discussion of specific equine myeloproliferative disorders.
- Description of diagnostic procedures including histochemical staining, bone marrow aspiration, and biopsy.
Main Results:
- A standardized nomenclature for equine hematopoietic and lymphoid neoplasia is proposed.
- Key features of individual lymphoproliferative and myeloproliferative disorders are detailed.
- The utility of histochemistry, bone marrow aspiration, and biopsy in diagnosis is highlighted.
Conclusions:
- Clearer terminology facilitates accurate diagnosis and understanding of equine hematopoietic and lymphoid neoplasms.
- A systematic approach to diagnostics is essential for effective management of these conditions in horses.